Skip to Main Content
TRC_PTL_New
Menu
    • Products
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • NatMed Advisor
      • NatMed Pro
      • NetCE All Access: APRN
      • NetCE All Access: MD
      • NetCE All Access: PA
      • NetCE All Access: RN
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber Insights: APRN
      • Prescriber Insights: MD
      • Prescriber Insights: PA
      • Prescriber's Letter
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Charts
    • COVID-19 Resources
    • Diabetes Resources
    • Immunization Resources
    • Natural Medicines Resources
  • Podcasts
  • Drug Charts
    • Do Not Crush List
    • First-Time Generics
    • Insulin Safety
    • New Drugs
    • Original Container Meds
    • More Charts >
  • Help
    • User Support
    • Contact Us
  • Go To CE/CME & Training

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

New! PTU Elite: Controlled Substances & Diversion prepares pharmacy technicians to manage controlled substances, covering everything from best practices for filling prescriptions to recordkeeping. Learn More.
  1. Home
  2. Browse
  3. Cardiology
  4. Resources
  5. Drugs

Drugs

  • Angina (19)
  • Antithrombotics (223)
  • Arrhythmias (116)
  • Blood Pressure (36)
  • Cardiovascular Disease and Depression (6)
  • Cholesterol (90)
  • Dyslipidemia (223)
  • Endocarditis (17)
  • Heart Disease (73)
  • Heart Failure (155)
  • Hypertension (230)
  • Hypotension (15)
  • Ischemic Heart Disease/Acute Coronary Syndromes (275)
  • Myocardial Infarction (42)
  • Peripheral Vascular Disease (5)
  • Pulmonary Arterial Hypertension (2)
  • Raynaud's (2)
  • Resources (673)
    • Charts (87)
    • Drug-Induced Cardiovascular Disease (198)
    • Drug-Induced Stroke (8)
    • Drugs (220)
      • ACE Inhibitors (19)
      • Alpha-Blockers (3)
      • Antiarrhythmics (7)
      • Anticoagulants (100)
      • Antihypertensives (13)
      • Antiplatelets (24)
      • ARBs (18)
      • Beta-Blockers (25)
      • CCBs (15)
      • Diuretics (15)
      • Fibrates (1)
      • Niacin (2)
      • Statins (46)
      • Thrombolytics (4)
    • Guidelines (93)
    • Letters (18)
    • Natural Medicines / Supplements (53)
    • Patient Education (44)
    • PL Voices (191)
    • Quality Measures (46)
  • Stroke (115)
196 - 210 of 220 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Article: conventional doses of warfarin to prevent recurrent venous thromboembolism September 2003
Other: Low-Intensity versus Conventional-Intensity Warfarin Therapy for Long-Term Prevention of Recurrent Venous Thromboembolism September 2003
Other: Can Patients be Safely Switched from Brand to Generic Warfarin? September 2003
Article: aspirin instead of warfarin to prevent stroke in some atrial fibrillation patients June 2003
Other: Utilization of Aspirin for Prevention of Stroke in Atrial Fibrillation June 2003
Article: new anticoagulant called Arixtra March 2002
Article: which antibiotics are safe to use in patients on warfarin March 2002
Other: New Drug: Arixtra (Fondaparinux) March 2002
Article: new guidelines on using low-molecular-weight heparins (Lovenox, Fragmin, Innohep) August 2001
Chart: New Guidelines for Low Molecular Weight Heparins August 2001
Article: stronger recommendations to use warfarin to prevent stroke in patients with atrial fibrillation January 1999
Article: ORAL vitamin K (phytonadione, Mephyton) is now recommended for many patients to reverse warfarin's anticoagulant effects January 1999
Other: Oral Vitamin K January 1999
Article: Lovenox (enoxaparin) at HOME August 1998
Article: Two new anticoagulants to prevent deep vein thrombosis July 1997
  • « Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • Next »
  • About Us
  • Our Mission
  • Our Team
  • Testimonials
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.

© Therapeutic Research Center. All Rights Reserved